Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 25:13:859177.
doi: 10.3389/fimmu.2022.859177. eCollection 2022.

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy

Affiliations
Review

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy

Mubin Tarannum et al. Front Immunol. .

Abstract

Natural killer cells constitute a part of the innate immune system that mediates an effective immune response towards virus-infected and malignant cells. In recent years, research has focused on exploring and advancing NK cells as an active immunotherapy platform. Despite major advances, there are several key challenges that need to be addressed for the effective translation of NK cell research to clinical applications. This review highlights some of these challenges and the innovative strategies being developed to overcome them, including in vitro expansion, in vivo persistence, infiltration to the tumor site, and prevention of exhaustion.

Keywords: NK cell exhaustion; immunotherapy; in vitro expansion; natural Killer (NK) cell; tumor infiltrating cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Figures

Figure 1
Figure 1
Overview of NK cell isolation, expansion, and in vivo persistence. NK cells can be isolated and/or generated from peripheral blood (PB), cord blood (CB), or human induced pluripotent stem cell (iPSC) sources. They are expanded ex vivo using various strategies including cytokine combinations, feeder cells, lipid membranes or biomaterials that carry surface markers to provide biochemical cues. In vivo persistence of NK cells can be accomplished using cytokines like IL-15 and/or cytokine-induced memory-like (CIML) NK cells that have shown long term persistence in an immune compatible environment. Illustration created using BioRender.com.
Figure 2
Figure 2
Strategies involved to improve the tumor infiltration of NK cells, overcome tumor escape and exhaustion. NK cells can be engineered to express CAR and specific chemokine receptors to increase their infiltration in solid tumors. Upon entry into the TME, NK cells can be impaired by its immune suppressive features. Blockade of inhibitory receptors (TIM-3, NKG2A, KIR) on NK cells can increase their antitumor cytotoxicity. Further, inhibition of immune-modulatory molecules (TGF-β) can prevent exhaustion in NK cells and maintain their cytotoxic features. Illustration created using BioRender.com.

Similar articles

Cited by

References

    1. Hu Y, Tian Z, Zhang C. Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects. Engineering (2019) 5:106–14. doi: 10.1016/j.eng.2018.11.015 - DOI
    1. Liu S, Galat V, Galat4 Y, Lee YKA, Wainwright D, Wu J. NK Cell-Based Cancer Immunotherapy: From Basic Biology to Clinical Development. J Hematol Oncol (2021) 14:7. doi: 10.1186/s13045-020-01014-w - DOI - PMC - PubMed
    1. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. . Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants. Science (2002) 295:2097–100. doi: 10.1126/science.1068440 - DOI - PubMed
    1. Ruggeri L, Mancusi A, Burchielli E, Capanni M, Carotti A, Aloisi T, et al. . NK Cell Alloreactivity and Allogeneic Hematopoietic Stem Cell Transplantation. Blood Cells Mol Dis (2008) 40:84–90. doi: 10.1016/j.bcmd.2007.06.029 - DOI - PubMed
    1. Lee DA. Cellular Therapy: Adoptive Immunotherapy With Expanded Natural Killer Cells. Immunol Rev (2019) 290:85–99. doi: 10.1111/imr.12793 - DOI - PubMed

Publication types

Substances